Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPMAT: Liposomal prednisolone to improve hemodialysis fistula maturation
2015-002488-40Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydrocortisone in Arteriovenous Fistula Nonmaturation, chronic kidney disease (CKD) and cardiac morbidity, sponsored by Leiden University Medical Center. Primary endpoint: Cephalic vein diameter at 6 weeks. Started Sep 2015; status: active.
02
Drugs
hydrocortisone
03
Conditions
Arteriovenous Fistula Nonmaturationchronic kidney disease (CKD)cardiac morbidity
Beyond the preview
Go deeper on 2015-002488-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002488-40.